We examined the extent of fetal lung hypoplasia and lung maturation using the amniotic lamellar body count (LBc) in congenital diaphragmatic hernia (cDh). Methods: We obtained 30 amniotic fluid samples from human cDh cases during cesarean section. We assessed LBc, magnetic resonance imaging (MRI), and ultrasound findings for predicting the prognosis of cDh. We collected newborn amniotic fluid and lung tissue at embryonic day (e)21 from normal and nitrofeninduced cDh rats (administered 100 mg orally at e9). amniotic LBcs in rats were measured using light microscopy. results: In human cDh, LBc was significantly higher in the surviving than in the deceased group (P < 0.01). a significant positive correlation was observed between LBc and percentage of fetal lung volume on MRI (P < 0.001; r = 0.716). In rats, LBc was significantly higher in controls than in cDh rats (P < 0.01) and correlated with fetal lung weight. conclusion: We conclude that LBc is useful for predicting lung hypoplasia in human cDh after 35 gestational weeks and in a rat model of nitrofen-induced cDh.
c ongenital diaphragmatic hernia (CDH) is a developmental discontinuity of the diaphragm that affects one in 2,500-5,000 live births (1) , resulting in pulmonary hypoplasia and pulmonary hypertension, which are often fatal. To improve clinical care and counseling, reliable prenatal parameters predicting fetal outcome in CDH are urgently needed. Prenatal predictors of fetal outcome in CDH have been reported to be focused mainly on the assessment of fetal lung volume (FLV). Ultrasound and magnetic resonance imaging (MRI) have been used to measure antenatal FLV and to qualify fetal pulmonary hypoplasia, but a gold-standard parameter has not yet been established.
The lamellar body count (LBC) was first described in 1989 (2) . Lamellar bodies are made up of a surfactant-containing lamellated structure and are secreted by type II pneumocytes (3) . The similarity of lamellar body size to platelet size permits the use of a standard automated hematologic cell counter to quantify the number of lamellar bodies in amniotic fluid (4) . Thus, the LBC is used to predict the degree of fetal lung maturity (FLM). Several studies have shown the LBC to accurately predict FLM (5) (6) (7) . The LBC can be measured quickly and inexpensively, such that it is equal to or even better than the lecithin-to-sphingomyelin ratio for predicting the occurrence of respiratory distress syndrome (7) .
In the current study, we hypothesized that if fetal pulmonary hypoplasia occurs because of CDH, the number of amniotic lamellar bodies secreted from the fetal lung into the amniotic cavity would be small. Therefore, we examined the LBC value in CDH neonates and confirmed it to be a useful predictor of CDH severity. Furthermore, given that LBC was originally a predictor of FLM, in the current study we also examined whether fetal lung maturation in CDH neonates is equivalent to that in normal neonates, using a rat CDH model.
Results

Registration of Clinical CDH Cases
We initially enrolled 30 cases diagnosed with CDH prenatally (Figure 1) . We excluded 11 cases (delivery before 35 weeks: n = 5; amniotic sampling failure: n = 3; trisomy 18: n = 2; neonatal death due to severe congenital heart disease: n = 1). Therefore, 19 cases were ultimately analyzed. We divided the newborns into two groups: infants who survived (n = 16) and those who died (n = 3).
Prognostic Findings for CDH in Humans
Background and prenatal findings of our CDH cases are shown in Table 1 . LBC was significantly higher in the surviving group than in the deceased group (1.6 ± 0.7 × 10 4 /µl vs. 0.5 ± 0.3 × 10 4 / µl; P < 0.01). The percentage of FLV on MRI was also significantly higher in the surviving than in the deceased group (36.6 ± 27.2 × 10 4 /µl vs. 11.3 ± 6.14 × 10 4 /µl; P < 0.05). We assessed LBC and percentage of FLV as potentially useful parameters for predicting neonatal nitric oxide (NO) (n = 12) and extracorporeal membrane oxygen (ECMO) (n = 4) requirements in the surviving group (n = 16). LBC was significantly lower in infants needing NO and ECMO therapies than in those not needing such therapies (1.5 ± 0.6 × 10 
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Amniotic lamellar body count in CDH P = 0.002, and 13.9 ± 7.5 vs. 44.2 ± 27.2 for ECMO; P = 0.008, respectively). Other prenatal predictors including gestational age at diagnosis, lung to head ratio (LHR), absolute FLV, liver herniation, and polyhydramnios did not significantly impact the outcomes of CDH infants. The rates of diabetes mellitus, preeclampsia, and fetal growth restriction did not differ significantly between the two groups. Furthermore, we analyzed the relationship between LBC and percentage of FLV (Figure 2) . A significant positive correlation was observed (P < 0.001; r = 0.716).
LBC and Lung Weight in a Rat CDH Model
In the rat experiment, we collected amniotic fluid and lung tissue from newborns at embryonic day (E)21 and confirmed the presence of lamellar bodies in both the amniotic fluid (Figure 3a) and type II alveolar cells of the lung (Figure 3b ) using electron microscopy. We also confirmed a similar lamellar body size in amniotic fluid and type II alveolar cells, of approximately 1-2 µm, comparable to the lamellar body findings in human amniotic fluid (2, 8) . Furthermore, after exposure of pregnant rats to a 100-mg dose of nitrofen, 48.8% (61 of 125) of newborns had diaphragmatic hernias. LBC was significantly higher in control rats than in CDH rats (3,527 ± 211/µl vs. 1,564 ± 358/µl; P < 0.01) (Figure 4a) . Furthermore, lung weight was also significantly higher in controls than in CDH newborn rats (0.143 ± 0.024 g vs. 0.071 ± 0.022 g; P < 0.01) (Figure 4b ). In addition, the LBC per unit lung weight in controls was similar to that in CDH rats (25.3 ± 1.59 × 10 3 /µl vs. 34.6 ± 15.2 × 10 3 /µl; P = 0.544).
Western Blotting for ABCA3 Expression in Fetal Rat Lung
We examined the expression of ABCA3 in lung tissues from newborn rats, delivered at E21, by western blotting (Figure 5a ). ABCA3 expression did not differ significantly between controls and CDH rats (P = 0.551) (Figure 5b ). Articles Watanabe et al.
DIsCussION
Pulmonary hypoplasia accounts for significant mortality and morbidity in neonates with CDH. Therefore, a precise predictor of FLV is required. In the current study, we found that LBC and percentage of FLV on MRI differed significantly between surviving and deceased CDH cases. Conversely, LHR did not differ significantly. LHR is reportedly useful for predicting subsequent survival (9) , but some recent studies could not confirm the prognostic value of LHR for survival or the necessity of ECMO therapy (10, 11) . In general, ultrasonography has certain disadvantages. Image resolution is sometimes limited by fetal position, maternal obesity, and oligohydramnios, which result in data variability among examiners. This can make it difficult to distinguish between fetal lung and liver on ultrasound. The FLV prediction using MRI has been reported to be accurate (12, 13) , but absolute FLV alone is not predictive of outcome because increasing lung volume with increasing gestational age could be a confounding factor (14) . Therefore, percentage of FLV on MRI is considered to be a more useful predictor in CDH (15) . In the current study, percentage of FLV on MRI, not absolute FLV, differed significantly in terms of the prediction of mortality in CDH. We examined factors such as liver herniation, complete contralateral pulmonary baseline on MRI, and polyhydramnios but found no significant differences, although positive findings for these factors correlated with a poor outcome (death in all cases). Amniotic LBC is reportedly an accurate predictor of FLM and has the advantage of being able to be determined as an absolute value on the basis of objective application of a cell counter. In the current study, we found that LBC correlated significantly with neonatal mortality in CDH after 35 gestational weeks. Moreover, LBC correlated closely with percentage of FLV on MRI. From this viewpoint, we hypothesize that LBC might be useful not only as a predictor of mortality but also as a predictor of hypoplastic lung in CDH after 35 gestational weeks. The lamellar body is a surfactant-containing lamellated structure that is secreted by type II pneumocytes (3). Therefore, LBC is used to estimate surfactant production in utero and, if lung maturation has been achieved in the fetus, to predict the extent of FLV.
Several studies have shown that diaphragmatic defects could be induced by administering a single 100-mg dose of nitrofen to pregnant rats between E8 and E11, and most significantly, that the defects produced were remarkably similar to those documented in human Bochdalek CDH with respect to their size, location, and accompanying intrusion of the abdominal viscera into the thoracic cavity (16-18). We administered a single 100-mg dose of nitrofen at E9 and confirmed the diaphragm defects in 48% of the rat pups. This rate is acceptable as compared with those in other reports (19, 20) .
In a rat model, we confirmed the presence of lamellar bodies in amniotic fluid as well as in alveolar type II cells using electron microscopy; we also confirmed that the size of these lamellar bodies was similar to that in humans. In human samples, we were able to examine amniotic LBCs using a hematologic cell counter in our hospital, but we could not apply this device to examine the lamellar bodies in the rat model. Hence, we counted rat lamellar bodies by light microscopy. LBCs determined by light microscopy reportedly correlate well with results obtained using standard hematologic cell counter techniques in human samples (21) . This is the first report demonstrating amniotic LBCs in a rat model.
In our CDH rat model, fetal lung weight was significantly decreased, and amniotic LBC was also significantly decreased 
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as compared with controls. The LBC per unit lung weight in CDH was similar to that in controls. Therefore, we can conclude that amniotic LBCs show a good correlation with fetal lung weight in CDH rat models, similar to the human CDH results. Furthermore, we examined ABCA3 expression by western blotting to assess fetal lung maturation in the rat. ABCA3 protein is expressed predominantly at the limiting membranes of the lamellar bodies in alveolar type II cells (22) and plays an essential role in pulmonary surfactant lipid metabolism, lamellar body biogenesis, surfactant protein-B processing, and lung development late in gestation (23) . In the current study, ABAC3 expressions were similar in CDH and non-CDH pups at full term. Controversy persists regarding whether or not humans with CDH and animal models of CDH have a surfactant deficiency. Our study revealed that fetal lung maturation was not delayed in CDH as compared with non-CDH in both humans and the rat nitrofen-induced model of CDH, observations that are consistent with recently reported results (1, 24, 25) . Our study has limitations. First, the CDH sample number for the human data was small. To evaluate the efficacy of LBC for predicting lung hypoplasia in CDH, a larger study would be necessary. Next, we must focus on the interpretation of LBC before 35 gestational weeks. LBC was originally a useful predictor for FLM, such that we could not evaluate lung hypoplasia using LBC when the fetal lung was immature. Before 35 gestational weeks, MRI is recommended for predicting lung hypoplasia in CDH. Finally, we dealt with an animal model of lung hypoplasia in CDH based on the teratogenic effects of nitrofen. A surgical model is potentially suitable for investigating interventional strategies in CDH, and further study would thus be necessary.
In conclusion, LBC is potentially useful for predicting hypoplastic lung in human CDH after 35 gestational weeks. LBC has advantages because it can be measured quickly and inexpensively, and it can be objectively determined as an absolute value using a cell counter. This is the first report predicting outcomes of CDH using LBC. Our results also addressed the fact that fetal lung maturation is not delayed in CDH as compared with controls for human CDH and for the nitrofen-induced rat CDH model. Although this study has limitations, we believe that amniotic LBC can serve a new tool for predicting the outcomes and the necessity of neonatal respiratory management of CDH and would therefore be useful for prenatal counseling.
MetHODs
Case Registration and Amniotic Fluid Collection in Clinical CDH
Data were collected from October 2006 to October 2011 at Nagoya University Hospital, Nagoya, Japan. Thirty amniotic fluid samples from CDH cases were obtained with signed informed consent. All amniotic fluid samples were obtained at cesarean section performed at 27-38 gestational weeks. We collected amniotic fluid by centesis while looking directly at the amniotic bag after incision of the myometrium during cesarean section. Samples were analyzed immediately after arrival at the laboratory without centrifugation, according to a standardized methodology for LBC reported by Neerhof et al. (6) . The LBC (per microliter) was determined using a platelet channel on the Sysmex XE-2100 (Sysmex, Kobe, Japan), and the procedure took no more than 30 min. At least 1 ml of amniotic fluid is needed to measure LBC. This study was approved by the ethics committee of Nagoya University Hospital.
Neonatal data such as gestational age at delivery, birth weight, sex, and prognosis including respiratory management (NO and ECMO) were extracted. Fetal growth restriction was defined as birth weight less than the mean − 1.5 SD for gestational age in Japan (26) .
Clinical characteristics of the mother such as preeclampsia and diabetes mellitus, both preexisting and gestational (27) , were documented for the assessment.
Prognostic Factors in Clinical CDH
The LHR is the ratio of the right lung area to the head circumference, as described by Metkus et al. (28) .
We calculated the percentage of right sided FLV, defined as the ratio of the observed right FLV to the expected right FLV, using MRI (Visart EX 1.5T; Toshiba, Tokyo, Japan), as described by Hayakawa et al. (15) . We also evaluated whether the right-sided pulmonary baseline was completely present. Magnetic resonance images with a complete baseline on at least one section were considered to have a complete pulmonary baseline. This finding has been reported to correlate with the severity of CDH (15) . Polyhydramnios was defined as an amniotic fluid index of >25 (29) .
Nitrofen-Induced Rat CDH Model
All animal experimental procedures were performed in accordance with the Nagoya University institutional guidelines for animal care, which conform to the National Institutes of Health animal care guidelines. Timed pregnant Sprague-Dawley rats were purchased from Chubu Kagaku Shizai (Nagoya, Japan). Rats were exposed to nitrofen (SigmaAldrich, Tokyo, Japan) on day 9 of pregnancy. Nitrofen (100 mg) was dissolved in 1 ml of olive oil. A rigid metal tube was then inserted into the rat's esophagus to administer the olive oil-nitrofen mixture to the stomach. At E21, we performed cesarean section and collected amniotic fluid and lung tissue from the newborns of both normal rats and those in which CDH had been induced by nitrofen.
Transmission Electron Microscope
Materials in fixing solution were centrifuged for 2 min at 4,000 rpm and then for 4 min at 6,000 rpm. Materials were washed three times in 0.1 mol/l phosphate buffer (pH 7.4) for a duration of 10 min each time and then postfixed with 1% osmium tetroxide for 1 h. After dehydration with a series of graded ethanol concentrations, ultrathin sections were cut vertically to the epidermal surface on an Ultracut S ultramicrotome (Reichert, Depew, NY). Sections were stained with uranyl acetate and lead citrate and examined with a JEOL-1400EX transmission electron microscope (Jeol, Tokyo, Japan).
Amniotic LBC in the Rat
We measured amniotic LBC using light microscopy in the rat model, as described by Hunter et al. (21) . In summary, a disposable plastic pipette was used to charge amniotic fluid onto a Burker-Turk hemocytometer (ERMA, Tokyo, Japan). The hemocytometer was viewed at ×400, and lamellar bodies were counted for each of the four corners of the BurkerTurk hemocytometer center grid, and the LBC was then divided by 4.
Western Blotting
Lung tissues from newborn rats were conserved at −80 °C in RNAlater (Qiagen, Tokyo, Japan). Then protein was extracted using protease inhibitor mixture tablets (Roche, Tokyo, Japan). The following antibody dilutions were used for western blot analysis: anti-ABCA3 (antimouse, incubated at 1:1,000 dilution; Covance, Tokyo, Japan), antimouse immunoglobulin G secondary antibodies (Cell Signaling Technology, Tokyo, Japan), and anti-β-actin (antimouse, incubated at 1:5,000 dilution; Abcam, Cambridge, UK). ABCA3 signals were normalized to β-actin signals for quantification.
Statistical Analysis
Statistical analysis of the data was performed with SPSS for Windows (V.19.0; SPSS, Chicago, IL) and Excel for Windows 2010 (Microsoft, Redmond, WA). Differences between the means were assessed using the Mann-Whitney-Wilcoxon test for unpaired samples. Wherever appropriate, Student's t-test was also used. A P value <0.05 was considered significant.
